Crenolanib

Results: 6



#Item
1Diagnostic Assay for Gastrointestinal stromal tumors (GIST) Background GIST can occur anywhere along the GI tract, but most often are found in the stomach or small intestine. Patients with GIST are treated by surgery and

Diagnostic Assay for Gastrointestinal stromal tumors (GIST) Background GIST can occur anywhere along the GI tract, but most often are found in the stomach or small intestine. Patients with GIST are treated by surgery and

Add to Reading List

Source URL: www.campus-technologies.de

Language: English - Date: 2015-02-18 08:33:03
2AstraZeneca  AZD0530 (saracatinib) Mechanism of Action

AstraZeneca AZD0530 (saracatinib) Mechanism of Action

Add to Reading List

Source URL: www.ncats.nih.gov

Language: English - Date: 2015-02-11 13:23:13
3PRELIMINARY REPORT OF CRENOLANIB IN THE TREATMENT OF ADVANCED PLATELET DERIVED GROWTH FACTOR A (PDGFRA) D842V MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST) 1 Mehren ,  2

PRELIMINARY REPORT OF CRENOLANIB IN THE TREATMENT OF ADVANCED PLATELET DERIVED GROWTH FACTOR A (PDGFRA) D842V MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST) 1 Mehren , 2

Add to Reading List

Source URL: www.gistsupport.org

Language: English - Date: 2013-01-18 17:46:23
4NCI Protocol #: PBTC-042 Local Protocol #: PBTC-042 Version date: 03 July 2014 Protocol Abstract and Schema PBTC-042: Phase I study of CDK 4-6 inhibitor PD[removed]in children with recurrent,

NCI Protocol #: PBTC-042 Local Protocol #: PBTC-042 Version date: 03 July 2014 Protocol Abstract and Schema PBTC-042: Phase I study of CDK 4-6 inhibitor PD[removed]in children with recurrent,

Add to Reading List

Source URL: www.pbtc.org

Language: English - Date: 2014-11-06 17:44:32
5Translational Medicine and New Therapies for the Treatment of GIST Brian Rubin, MD, PhD Anatomic Pathology and Molecular Genetics

Translational Medicine and New Therapies for the Treatment of GIST Brian Rubin, MD, PhD Anatomic Pathology and Molecular Genetics

Add to Reading List

Source URL: www.gistsupport.org

Language: English - Date: 2011-10-02 15:21:23
6CRENOLANIB, A NOVEL TYPE I, MUTANT-SPECIFIC INHIBITOR OF CLASS III RECEPTOR TYROSINE KINASES, PREFERENTIALLY BINDS TO PHOSPHORYLATED KINASES 1

CRENOLANIB, A NOVEL TYPE I, MUTANT-SPECIFIC INHIBITOR OF CLASS III RECEPTOR TYROSINE KINASES, PREFERENTIALLY BINDS TO PHOSPHORYLATED KINASES 1

Add to Reading List

Source URL: www.gistsupport.org

Language: English - Date: 2013-01-20 11:10:44